Zura Bio Limited Class A Ordinary Shares (ZURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $119.44M
Last updated: Nov 17, 2026 at 11:06 AM ET
Zura Bio Limited Class A Ordinary Shares (ZURA) Earnings: Report Dates and Results
Zura Bio Limited Class A Ordinary Shares (ZURA) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.20, above the -$0.22 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ZURA has an expected report date of Mar 17, 2027.
Earnings History
Of the 14 quarters below that had an estimate, ZURA beat 6 and missed 8. The widest gap in the table came in the quarter ended Jun 30, 2023, when EPS landed 424.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.20 | -$0.22 | -$0.24 - -$0.18 | +9.09% | Beat | N/A | 5 | 0 up, 1 down | Oct 27, 2026 |
| Jun 30, 2026 | -$0.21 | -$0.20 | N/A | -5.00% | Miss | N/A | 3 | 0 up, 0 down | Aug 11, 2026 |
| Mar 31, 2026 | -$0.22 | -$0.18 | -$0.18 - -$0.18 | -22.22% | Miss | N/A | 1 | 0 up, 0 down | May 7, 2026 |
| Dec 31, 2025 | -$0.49 | -$0.15 | -$0.15 - -$0.15 | -226.67% | Miss | N/A | 1 | 0 up, 0 down | Mar 19, 2026 |
| Sep 30, 2025 | -$0.21 | -$0.18 | -$0.21 - -$0.15 | -16.67% | Miss | N/A | 7 | 2 up, 1 down | Nov 13, 2025 |
| Jun 30, 2025 | -$0.17 | -$0.18 | N/A | +5.56% | Beat | N/A | N/A | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.19 | -$0.16 | N/A | -18.75% | Miss | N/A | N/A | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$0.10 | -$0.24 | N/A | +58.33% | Beat | N/A | 7 | 2 up, 1 down | Mar 25, 2025 |
| Sep 30, 2024 | -$0.26 | -$0.13 | -$0.14 - -$0.10 | -100.00% | Miss | N/A | 6 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.17 | -$0.15 | -$0.19 - -$0.11 | -13.33% | Miss | N/A | 6 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$0.02 | -$0.24 | -$0.29 - -$0.15 | +91.67% | Beat | N/A | 4 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.19 | -$0.23 | -$0.27 - -$0.19 | +17.39% | Beat | -575.0% | 5 | 0 up, 0 down | Mar 26, 2024 |
| Sep 30, 2023 | -$0.18 | -$0.23 | -$0.30 - -$0.20 | +21.74% | Beat | -700.0% | 5 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$1.31 | -$0.25 | N/A | -424.00% | Miss | -1107.7% | N/A | N/A | Aug 14, 2023 |
| Mar 31, 2023 | -$2.76 | N/A | N/A | N/A | N/A | -5615.4% | N/A | N/A | May 12, 2023 |
| Dec 31, 2022 | $0.04 | N/A | N/A | N/A | N/A | -15.6% | N/A | N/A | Mar 30, 2023 |
| Sep 30, 2022 | $0.03 | N/A | N/A | N/A | N/A | -91.4% | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | $0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2022 |
| Mar 31, 2022 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2022 |
| Dec 31, 2021 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2022 |
| Sep 30, 2021 | $0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2021 |
| Jun 30, 2021 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Sep 28, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.06, after -$0.55 the year before. It was $0.40 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.06 | N/A |
| Dec 31, 2024 | -$0.55 | N/A |
| Dec 31, 2023 | -$4.44 | -1875.1% |
| Dec 31, 2022 | $0.25 | -37.1% |
| Dec 31, 2021 | $0.40 | N/A |
Frequently Asked Questions About ZURA
When is Zura Bio Limited Class A Ordinary Shares's next earnings date?
Zura Bio Limited Class A Ordinary Shares's next earnings report is expected for Mar 17, 2027.
Did ZURA beat earnings estimates last quarter?
Yes. Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.20 for the quarter ended Sep 30, 2026, above the -$0.22 estimate, a 9.09% surprise.
What EPS do analysts expect from ZURA next quarter?
The consensus EPS estimate for Zura Bio Limited Class A Ordinary Shares for the quarter ending Dec 31, 2026 is -$0.20 from 10 analysts, with estimates from -$0.23 to -$0.16.
How often does ZURA beat earnings estimates?
Zura Bio Limited Class A Ordinary Shares beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -27.04%.
ZURA pages: Overview, Earnings, Forecast, Financials, Competitors